| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 6.954 | - | 33.624 | 36.651 | - | 93.758 | 94.862 | 43.478 | 118.400 |
| Total Income - EUR | - | 6.954 | - | 43.294 | 36.651 | - | 93.758 | 94.862 | 43.480 | 118.948 |
| Total Expenses - EUR | - | 14.919 | - | 31.051 | 22.908 | - | 71.441 | 65.750 | 27.084 | 84.976 |
| Gross Profit/Loss - EUR | - | -7.965 | - | 12.244 | 13.743 | - | 22.317 | 29.112 | 16.396 | 33.972 |
| Net Profit/Loss - EUR | - | -8.149 | - | 12.039 | 13.561 | - | 21.545 | 28.306 | 16.032 | 30.654 |
| Employees | - | 1 | - | 4 | 4 | - | 5 | 5 | 4 | 3 |
Check the financial reports for the company - Eucriss Sano Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 0 | - | 0 | 0 | - | 0 | 0 | 129.932 | 128.277 |
| Current Assets | - | 10.609 | - | 37.429 | 44.101 | - | 123.353 | 95.428 | 37.558 | 51.784 |
| Inventories | - | 0 | - | 699 | 685 | - | 657 | 659 | 0 | 0 |
| Receivables | - | 3.950 | - | 35.769 | 25.119 | - | 119.599 | 84.235 | 5.720 | 28.016 |
| Cash | - | 6.659 | - | 961 | 18.297 | - | 3.097 | 10.534 | 31.838 | 23.768 |
| Shareholders Funds | - | -8.060 | - | 14.238 | 27.904 | - | 57.560 | 86.044 | 28.276 | 42.829 |
| Social Capital | - | 89 | - | 86 | 84 | - | 81 | 81 | 81 | 80 |
| Debts | - | 18.670 | - | 23.191 | 16.196 | - | 65.793 | 9.383 | 139.214 | 137.231 |
| Income in Advance | - | 0 | - | 0 | 0 | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Eucriss Sano Med Srl